First Time Loading...

ADMA Biologics Inc
NASDAQ:ADMA

Watchlist Manager
ADMA Biologics Inc Logo
ADMA Biologics Inc
NASDAQ:ADMA
Watchlist
Price: 6.55 USD 1.71% Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

ADMA Price Targets Summary
ADMA Biologics Inc

Wall Street analysts forecast ADMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADMA is 8.54 USD with a low forecast of 7.58 USD and a high forecast of 10.5 USD.

Lowest
Price Target
7.58 USD
16% Upside
Average
Price Target
8.54 USD
30% Upside
Highest
Price Target
10.5 USD
60% Upside
ADMA Biologics Inc Competitors:
Price Targets
CDNA
CareDx Inc
67% Upside
2INV
2Invest AG
72% Downside
LYEL
Lyell Immunopharma Inc
182% Upside
068270
Celltrion Inc
34% Upside
KMDA
Kamada Ltd
138% Upside
TRDA
Entrada Therapeutics Inc
72% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
9% Upside
PROB
Probi AB
52% Upside

Revenue
Forecast

Revenue Estimate
ADMA Biologics Inc

For the last 8 years the compound annual growth rate for ADMA Biologics Inc's revenue is 56%. The projected CAGR for the next 3 years is 20%.

56%
Past Growth
20%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
ADMA Biologics Inc

The compound annual growth rate of ADMA Biologics Inc's operating income for the next 3 years is 91%.

N/A
Past Growth
91%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
ADMA Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADMA's stock price target?
Price Target
8.54 USD

According to Wall Street analysts, the average 1-year price target for ADMA is 8.54 USD with a low forecast of 7.58 USD and a high forecast of 10.5 USD.

What is ADMA Biologics Inc's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for ADMA Biologics Inc's revenue is 56%. The projected CAGR for the next 3 years is 20%.

What is ADMA Biologics Inc's Operating Income forecast?
Projected CAGR
91%

The compound annual growth rate of ADMA Biologics Inc's operating income for the next 3 years is 91%.